Cysteinyl Leukotriene Synthesis via Phospholipase A2 Group IV Mediates Exercise-induced Bronchoconstriction and Airway Remodeling

Am J Respir Cell Mol Biol. 2020 Jul;63(1):57-66. doi: 10.1165/rcmb.2019-0325OC.

Abstract

It is well known that the prevalence of asthma is higher in athletes, including Olympic athletes, than in the general population. In this study, we analyzed the mechanism of exercise-induced bronchoconstriction by using animal models of athlete asthma. Mice were made to exercise on a treadmill for a total duration of 1 week, 3 weeks, or 5 weeks. We analyzed airway responsiveness, BAL fluid, lung homogenates, and tissue histology for each period. In mice that were treated (i.e., the treatment model), treatments were administered from the fourth to the fifth week. We also collected induced sputum from human athletes with asthma and analyzed the supernatants. Airway responsiveness to methacholine was enhanced with repeated exercise stimulation, although the cell composition in BAL fluid did not change. Exercise induced hypertrophy of airway smooth muscle and subepithelial collagen deposition. Cysteinyl-leukotriene (Cys-LT) levels were significantly increased with exercise duration. Montelukast treatment significantly reduced airway hyperresponsiveness (AHR) and airway remodeling. Expression of PLA2G4 (phospholipase A2 group IV) and leukotriene C4 synthase in the airway epithelium was upregulated in the exercise model, and inhibition of PLA2 ameliorated AHR and airway remodeling, with associated lower levels of Cys-LTs. The levels of Cys-LTs in sputum from athletes did not differ between those with and without sputum eosinophilia. These data suggest that AHR and airway remodeling were caused by repeated and strenuous exercise. Cys-LTs from the airway epithelium, but not inflammatory cells, may play an important role in this mouse model.

Keywords: airway hyperresponsiveness; airway remodeling; cysteinyl-leukotriene; exercise-induced bronchoconstriction; phospholipase A2 group IV.

MeSH terms

  • Acetates / pharmacology
  • Airway Remodeling / drug effects
  • Airway Remodeling / physiology*
  • Animals
  • Asthma / drug therapy
  • Asthma / metabolism
  • Bronchial Hyperreactivity / drug therapy
  • Bronchial Hyperreactivity / metabolism
  • Bronchoconstriction / drug effects
  • Bronchoconstriction / physiology*
  • Cyclopropanes
  • Cysteine / metabolism*
  • Female
  • Group II Phospholipases A2 / metabolism*
  • Leukotrienes / metabolism*
  • Leukotrienes / pharmacology
  • Lung / drug effects
  • Lung / metabolism
  • Methacholine Chloride / pharmacology
  • Mice
  • Mice, Inbred BALB C
  • Physical Conditioning, Animal / physiology*
  • Quinolines / pharmacology
  • Respiratory Hypersensitivity / drug therapy
  • Respiratory Hypersensitivity / metabolism
  • Sulfides

Substances

  • Acetates
  • Cyclopropanes
  • Leukotrienes
  • Quinolines
  • Sulfides
  • cysteinyl-leukotriene
  • Methacholine Chloride
  • Group II Phospholipases A2
  • Cysteine
  • montelukast